Artículos por temáticas

Advances in blood biomarkers for Alzheimer disease (AD): A review

Assfaw AD, Schindler SE, Morris JC.

Kaohsiung J Med Sci. 2024 Aug;40(8):692-698. doi: 10.1002/kjm2.12870. Epub 2024 Jun 18.

Young-Onset Alzheimer Dementia Due to a Novel Pathogenic Presenilin 1 Variant Initially Misdiagnosed as Autoimmune Encephalitis

Ronchi NR, Castro MA, Coutinho AM, Lucato LT, Silva GD, Brucki SM, Kok F, Trés ES, Nóbrega PR, Freua F, Nitrini R, Simabukuro MM.

Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200280. doi: 10.1212/NXI.0000000000200280. Epub 2024 Jul 18.

Naming as a window to word retrieval changes in healthy and pathological ageing: Methodological considerations

Martínez-Ferreiro S.

Int J Lang Commun Disord. 2024 Jan-Feb;59(1):68-83. doi: 10.1111/1460-6984.12827. Epub 2022 Dec 12.

Case report: Rapidly progressive neurocognitive disorder with a fatal outcome in a patient with PU.1 mutated agammaglobulinemia

Miskovic R, Ljubicic J, Bonaci-Nikolic B, Petkovic A, Markovic V, Rankovic I, Djordjevic J, Stankovic A, Klaassen K, Pavlovic S, Stojanovic M.

Front Immunol. 2024 Mar 4;15:1324679. doi: 10.3389/fimmu.2024.1324679. eCollection 2024.

Soluble Biomarkers of Cerebrovascular Pathologies

Foley KE, Wilcock DM.

Stroke. 2024 Apr;55(4):801-811. doi: 10.1161/STROKEAHA.123.044172. Epub 2024 Mar 25.

How reactions to a brain scan result differ for adults based on self-identified Black and White race

Stites SD, Largent EA, Schumann R, Harkins K, Sankar P, Krieger A.

Alzheimers Dement. 2024 Mar;20(3):1527-1537. doi: 10.1002/alz.13558. Epub 2023 Nov 29.

The Olfactory Trail of Neurodegenerative Diseases

Franco R, Garrigós C, Lillo J.

Cells. 2024 Apr 2;13(7):615. doi: 10.3390/cells13070615.

Measurement properties of the German version of the Cambridge examination for mental disorders of older people with Down syndrome and others with intellectual disabilities (CAMDEX-DS)

Loosli SV, Neumann LC, Wlasich E, Prix C, Koll L, Weidinger E, Vöglein J, Wagemann O, Danek A, Nübling G, Levin J.

J Intellect Dev Disabil. 2024 Dec;49(4):402-414. doi: 10.3109/13668250.2024.2317794. Epub 2024 Feb 29.

Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases

Saleem A, Javed M, Akhtar MF, Sharif A, Akhtar B, Naveed M, Saleem U, Baig MMFA, Zubair HM, Bin Emran T, Saleem M, Ashraf GM.

Curr Gene Ther. 2024;24(2):122-134. doi: 10.2174/0115665232261931231006103234.

Psychosocial implications of learning amyloid PET results in an observational cohort

Clark LR, Erickson CM, Chin NA, Basche KE, Ketchum FB, Rosario HL, Peterson AJ, Eveler ML, Johnson SC.

Alzheimers Dement. 2024 Sep;20(9):6579-6589. doi: 10.1002/alz.14153. Epub 2024 Aug 11.

Practicalities (and real-life experiences) of dementia in adults with Down syndrome

Harisinghani A, Cottrell C, Donelan K, Lam AD, Pulsifer M, Santoro SL.

Am J Med Genet C Semin Med Genet. 2024 Dec;196(4):e32098. doi: 10.1002/ajmg.c.32098. Epub 2024 Jul 5.

[Olfaction and Alzheimer's disease: from deficits to therapeutic hopes]

Lopis D.

Geriatr Psychol Neuropsychiatr Vieil. 2024 Dec 1;22(4):394-404. doi: 10.1684/pnv.2024.1197.

The potential roles of salivary biomarkers in neurodegenerative diseases

Jiao LL, Dong HL, Liu MM, Wu PL, Cao Y, Zhang Y, Gao FG, Zhu HY.

Neurobiol Dis. 2024 Apr;193:106442. doi: 10.1016/j.nbd.2024.106442. Epub 2024 Feb 19.

Re: Shahim et al., 2024 "Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction"

Tamborska AA, Bray CF, Kurth T.

Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):476-477. doi: 10.1093/ehjcvp/pvae041.

Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms

Walker L, Attems J.

J Parkinsons Dis. 2024;14(1):35-52. doi: 10.3233/JPD-230154.